menu
    • menu

    Company profile for OSE Immunotherapeutics SA

    NEW Drugs in Dev: 12
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmmune diseases. The company utilizes several scientific and technological approaches including neoepitopes and agonist/antagonist monoclonal antibodies, all ideally positioned to fight cancer and autoimmune diseases. Our first-in-class pipeline offers a diver...
    OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmmune diseases. The company utilizes several scientific and technological approaches including neoepitopes and agonist/antagonist monoclonal antibodies, all ideally positioned to fight cancer and autoimmune diseases. Our first-in-class pipeline offers a diversified risk profile, ranging from registrational to clinical stage to R&D.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OSE Immunotherapeutics SAFrance Flag
    Country
    Country
    France
    Address
    Address
    22, boulevard Benoni Goullin \n44200 Nantes
    Telephone
    Telephone
    33 (0) 2 28 29 10 10
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ose-immuno.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ose-immunotherapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/OSEIMMUNO

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OSE Immunotherapeutics to Implement Bridge Equity Financing
    OSE Immunotherapeutics to Implement Bridge Equity Financing

    28 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/28/3303206/0/en/ose-immunotherapeutics-to-implement-a-flexible-bridge-equity-financing.html

    GLOBENEWSWIRE
    28 May 2026
    Share Share
    OSE Turn Up Heat on Ovarian Cancer With Ph2 Win, Support Keytruda
    OSE Turn Up Heat on Ovarian Cancer With Ph2 Win, Support Keytruda

    22 May 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ose-turns-heat-ovarian-cancer-phase-2-keytruda-supported-win

    FIERCE BIOTECH
    22 May 2026
    Share Share
    OSE Welcomes FDA Orphan Drug Tag for Heart Transplant Drug
    OSE Welcomes FDA Orphan Drug Tag for Heart Transplant Drug

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281280/0/en/ose-immunotherapeutics-welcomes-fda-orphan-drug-designation-granted-to-pegrizeprument-vel-101-for-prevention-of-organ-rejection-in-heart-transplant-patients.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    OSE Immunotherapeutics Presents Tedopi Phase 2 Results
    OSE Immunotherapeutics Presents Tedopi Phase 2 Results

    23 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-23/ose-immunotherapeutics-announces-presentation-of-tedova-phase-2-topline-results-of-tedopi-in-ovarian-cancer-at-the-asco-2026-meeting

    PHARMIWEB
    23 Apr 2026
    Share Share
    OSE Immunotherapeutics to Present a Novel, First-in-Class
    OSE Immunotherapeutics to Present a Novel, First-in-Class

    15 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-15/ose-immunotherapeutics-to-present-a-novel-first-in-class-fpr2-agonist-monoclonal-antibody-in-the-resolution-of-chronic-inflammation-at-the-aai-2026

    PHARMIWEB
    15 Apr 2026
    Share Share
    OSE Immunotherapeutics Evolves Its Leadership Team
    OSE Immunotherapeutics Evolves Its Leadership Team

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273728/0/en/OSE-Immunotherapeutics-Evolves-its-Leadership-Team.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search